You are here

  • Home
  • Archive
  • Volume 17, Issue 1
  • Adding very low nicotine content cigarettes to nicotine replacement therapy and behavioural support increases abstinence at 6 months after the quit date

Article Text

Article menu
PDF
Health promotion
Randomised controlled trial
Adding very low nicotine content cigarettes to nicotine replacement therapy and behavioural support increases abstinence at 6 months after the quit date
  1. Sharon Cummins
  1. Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, California, USA
  1. Correspondence to : Dr Sharon Cummins
    Department of Family and Preventive Medicine, University of California, San Diego (UCSD), 9500 Gilman Drive, MC0905, La Jolla, CA 92093-0905, USA; scummins{at}ucsd.edu

http://dx.doi.org/10.1136/eb-2012-101160

Statistics from Altmetric.com

    Commentary on Walker N, Howe C, Bullen C, et al. The combined effect of very low-nicotine content cigarettes, used as an adjunct to usual Quitline care (nicotine replacement therapy and behavioural support), on smoking cessation: a randomised controlled trial. Addiction 2012;107:1857–67.

    Implications for practice and research

    • Adding very low nicotine content (VLNC) cigarettes to nicotine replacement therapy (NRT) and behavioural support may help some smokers become abstinent.

    • Use of VLNCs did not increase serious adverse health events when used with NRT.

    • We cannot assume VLNCs would be as safe without NRT because there may be more compensatory smoking.

    Context

    There are proven interventions to help smokers quit, both behavioural (group, individual, telephone-based counselling) and pharmacological (NRT, medications).1 This study examined using VLNCs to help smokers quit. VLNCs mimic the act of smoking and are thought to address non-nicotine aspects of smoking including hand-to-mouth …

    View Full Text

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Copyright information:

    Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions